YaoGeJu

Company directoryChina company filings

Beijing Beilu Pharmaceutical Co., Ltd.

As of 17 November 2026, for the company name Beijing Beilu Pharmaceutical Co., Ltd. as recorded, 7 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 36 records, across 25 drug names; since 21 August 2026, the records list Accepted: 2 applications, No longer listed under review: 1 application; the chemical-drug catalogue lists 27 active records with this name as holder; 19 active API registrations list this name as first registered company; 6 further acceptance records name it after the first applicant.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/17
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.

Drug filings

36 acceptance records as first applicant, grouped into 25 source drug names. Source data as of 2026/11/17.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Iohexol Injection 5 records · Latest accepted 2026/10/27

Supplement · 5

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2650212Supplement2026/10/27Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
CYHB2650211Supplement2026/10/27Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
CYHB2500255Supplement2025/02/08Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
CYHB2300588Supplement2023/03/22Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
CYHB2102448Supplement2021/12/28Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Gadoteridol Injection 2 records · Latest accepted 2026/03/04

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600610Generic2026/03/04Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
CYHS2600609Generic2026/03/04Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Ioversol Injection 1 records · Latest accepted 2026/01/13

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600053Supplement2026/01/13Beijing Beilu Pharmaceutical Co., Ltd.; Chengdu Brilliant Pharmaceutical Co., Ltd.CDE ↗
Iobitridol Injection 2 records · Latest accepted 2025/10/14

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503674Generic2025/10/14Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
CYHS2503673Generic2025/10/14Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
米格列醇片 · No verified English name 1 records · Latest accepted 2025/07/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502479Generic2025/07/11Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Bimatoprost Eye Drops 1 records · Latest accepted 2025/06/19

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502196Generic2025/06/19Beijing Beilu Pharmaceutical Co., Ltd.; Jin Yao Yong Guang (Hebei) Pharmaceutical Co., Ltd. romanizedCDE ↗
Upadacitinib Sustained-release Tablets 1 records · Latest accepted 2025/06/14

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502132Generic2025/06/14Beijing Beilu Pharmaceutical Co., Ltd.; Hu Zhou Ya Se Pharmaceutical Co., Ltd. romanizedCDE ↗
Iopamidol Injection 2 records · Latest accepted 2025/05/16

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500986Supplement2025/05/16Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
CYHB2500984Supplement2025/05/16Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2024/12/09

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404253Generic2024/12/09Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
CYHS2404252Generic2024/12/09Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Mupirocin Ointment 1 records · Latest accepted 2024/11/07

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403795Generic2024/11/07Beijing Beilu Pharmaceutical Co., Ltd.; Jiangsu Ziyond Pharmaceutical Co., Ltd.CDE ↗
Tranexamic Acid Tablets 1 records · Latest accepted 2024/09/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402988Generic2024/09/10Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Sildenafil Citrate Oral Disintegrating Tablets 1 records · Latest accepted 2024/08/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402758Generic2024/08/23Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Iopromide Injection 1 records · Latest accepted 2024/08/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402660Generic2024/08/15Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Iomeprol Injection 1 records · Latest accepted 2024/06/18

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401810Generic2024/06/18Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Gadopentetic Acid Dimeglumine Salt Injection 3 records · Latest accepted 2024/05/17

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400664Supplement2024/05/17Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
CYHB2350390Supplement2023/04/26Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
CYHB2350389Supplement2023/04/26Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Pioglitazone and Metformin Hydrochloride Tablets 1 records · Latest accepted 2024/04/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401078Generic2024/04/11Beijing Beilu Pharmaceutical Co., Ltd.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanizedCDE ↗
九味镇心颗粒 · No verified English name 1 records · Latest accepted 2024/01/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2400167Supplement2024/01/29Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
复方聚乙二醇电解质散(III) · No verified English name 1 records · Latest accepted 2023/08/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302119Generic2023/08/15Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
西甲硅油乳剂 · No verified English name 1 records · Latest accepted 2023/07/29

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302027Generic2023/07/29Beijing Beilu Pharmaceutical Co., Ltd.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanizedCDE ↗
Gadobutrol Injection 1 records · Latest accepted 2023/05/17

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301081Supplement2023/05/17Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Gadoteric Acid Meglumine Salt Injection 1 records · Latest accepted 2023/02/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300651Generic2023/02/27Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Gadobenate Dimeglumine Injection 1 records · Latest accepted 2023/01/19

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350081Supplement2023/01/19Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets 1 records · Latest accepted 2022/09/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201525Generic2022/09/15Beijing Beilu Pharmaceutical Co., Ltd.; Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanizedCDE ↗
Repaglinide Tablets 1 records · Latest accepted 2022/07/21

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250454Supplement2022/07/21Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Pramipexole Dihydrochloride Prolonged-release Tablets 2 records · Latest accepted 2021/09/06

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101674Generic2021/09/06Beijing Beilu Pharmaceutical Co., Ltd.; Li Pin Pharma (Xiamen) Co., Ltd. romanizedCDE ↗
CYHS2101673Generic2021/09/06Beijing Beilu Pharmaceutical Co., Ltd.; Li Pin Pharma (Xiamen) Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

3 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 2 applicationsNo longer listed under review: 1 application

  1. 2026/11/14No longer listed under review

    米格列醇片 · No verified English name

    CYHS2502479

    Fact date: 2026/11/14 · Date added to this site: 2026/11/14

    Accepted: 2025/07/11

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  2. 2026/10/27Accepted

    Iohexol Injection

    CYHB2650212

    Fact date: 2026/10/27 · Date added to this site: 2026/10/28

    View source ↗
  3. 2026/10/27Accepted

    Iohexol Injection

    CYHB2650211

    Fact date: 2026/10/27 · Date added to this site: 2026/10/28

    View source ↗

Under review

7 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Iohexol Injection CYHB2650212Supplement2026/10/27Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Iohexol Injection CYHB2650211Supplement2026/10/27Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Gadoteridol Injection CYHS2600610Generic2026/03/04Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Gadoteridol Injection CYHS2600609Generic2026/03/04Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Iobitridol Injection CYHS2503674Generic2025/10/14Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Iobitridol Injection CYHS2503673Generic2025/10/14Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Upadacitinib Sustained-release Tablets CYHS2502132Generic2025/06/14Beijing Beilu Pharmaceutical Co., Ltd.; Hu Zhou Ya Se Pharmaceutical Co., Ltd. romanizedCDE ↗

Catalogue holder records

27 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Vonoprazan Fumarate TabletsBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202649002026/06/23Generic approved under the new chemical-drug registration classificationCDE ↗
Vonoprazan Fumarate TabletsBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202648992026/06/23Generic approved under the new chemical-drug registration classificationCDE ↗
Ioversol InjectionBeijing Beilu Pharmaceutical Co., Ltd.Chengdu Brilliant Pharmaceutical Co., Ltd.国药准字H202642602026/05/07Generic approved under the new chemical-drug registration classificationCDE ↗
Iopromide InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202634682026/02/25Generic approved under the new chemical-drug registration classificationCDE ↗
Sildenafil Citrate Oral Disintegrating TabletsBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202563902025/12/22Generic approved under the new chemical-drug registration classificationCDE ↗
吡格列酮二甲双胍片(15mg/500mg) · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized国药准字H202562052025/12/09Generic approved under the new chemical-drug registration classificationCDE ↗
Iomeprol InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202558382025/11/04Generic approved under the new chemical-drug registration classificationCDE ↗
复方聚乙二醇电解质散(III) · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202533652025/02/11Generic approved under the new chemical-drug registration classificationCDE ↗
Gadopentetic Acid Dimeglumine Salt InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H200130882024/10/15Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Gadopentetic Acid Dimeglumine Salt InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H108600022024/10/15Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Gadoteric Acid Meglumine Salt InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202443442024/06/28Generic approved under the new chemical-drug registration classificationCDE ↗
Paroxetine Hydrochloride Enteric-Coated Sustained-Release TabletsBeijing Beilu Pharmaceutical Co., Ltd.Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized国药准字H202436342024/04/30Generic approved under the new chemical-drug registration classificationCDE ↗
Gadobutrol InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202470722024/04/19Generic approved under the new chemical-drug registration classificationCDE ↗
Gadobenate Dimeglumine InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202030082024/03/15Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Pramipexole Dihydrochloride Prolonged-release TabletsBeijing Beilu Pharmaceutical Co., Ltd.Li Pin Pharma (Xiamen) Co., Ltd. romanized国药准字H202338282023/06/30Generic approved under the new chemical-drug registration classificationCDE ↗
Pramipexole Dihydrochloride Prolonged-release TabletsBeijing Beilu Pharmaceutical Co., Ltd.Li Pin Pharma (Xiamen) Co., Ltd. romanized国药准字H202338272023/06/30Generic approved under the new chemical-drug registration classificationCDE ↗
Repaglinide TabletsBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H201133802023/05/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Gadobutrol InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202231772022/03/29Generic approved under the new chemical-drug registration classificationCDE ↗
Iopamidol InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H201531032022/02/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Iopamidol InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H201841132022/02/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Repaglinide TabletsBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H202171352021/12/13Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Gadopentetic Acid Dimeglumine Salt InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H109600452021/07/15Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Gadopentetic Acid Dimeglumine Salt InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H108600012021/07/15Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Iodixanol InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H201134652021/05/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Iodixanol InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H201530012021/05/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Iohexol InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H199802182021/04/06Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Iohexol InjectionBeijing Beilu Pharmaceutical Co., Ltd.Beijing Beilu Pharmaceutical Co., Ltd.国药准字H200538002021/04/06Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

19 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.

NameCompany / applicantRegistration numberStatusSource update dateView source
盐酸苯海索 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20260000027I2026/01/29CDE ↗
维生素A棕榈酸酯 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20250001424I2025/12/29CDE ↗
乌帕替尼 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20250001383I2025/12/25CDE ↗
消旋α-生育酚 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20250001334I2025/12/11CDE ↗
钆特醇 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20250001318I2025/12/08CDE ↗
二硫化硒 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20250001261I2025/11/27CDE ↗
钆布醇 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20240001249A2026/04/21CDE ↗
富马酸伏诺拉生 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20240000988A2026/02/25CDE ↗
盐酸达克罗宁 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20240000874A2026/05/12CDE ↗
硫酸钠 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20230000271A2026/07/31CDE ↗
钆特酸葡胺 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20220001195A2026/08/15CDE ↗
瑞格列奈 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20210000275A2024/09/27CDE ↗
钆布醇 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20200000909A2026/09/16CDE ↗
钆喷酸葡胺 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20190009524A—CDE ↗
瑞格列奈 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20190008297A—CDE ↗
碘海醇 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20190008250A2023/03/24CDE ↗
格列美脲 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20190007874A—CDE ↗
钆喷酸葡胺 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20170001940A2025/01/16CDE ↗
钆贝葡胺 · No verified English nameBeijing Beilu Pharmaceutical Co., Ltd.Y20170000223A2024/10/18CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

6 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
米格列醇片 · No verified English name CYHB2601333Supplement2026/07/14Lu Zhi Bao Pharma Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Tranexamic Acid Tablets CYHB2501794Supplement2025/09/09Hainan Yao Gu Yun Bio Technology Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Ioversol Injection CYHS2501534Generic2025/04/23Chengdu Tian Zhi Yi Shang Pin Pharmaceuticals Technology Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Ioversol Injection CYHS2500841Generic2025/02/25Chengdu Tian Zhi Yi Shang Pin Pharmaceuticals Technology Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
Ioversol Injection CYHS2500626Generic2025/02/08Shandong Ru Zhi Biopharmaceuticals Technology Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗
九味镇心颗粒 · No verified English name CYZB2402361Supplement2024/11/29Lu Zhi Bao Pharma Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/17
Chemical-drug catalogue
Last successful update: 2026/11/17
API registrations
Last successful update: 2026/11/17
NMPA drug delivery notices
Last successful update: 2026/11/17

Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.